Elinor Karlsson to Immunohistochemistry
This is a "connection" page, showing publications Elinor Karlsson has written about Immunohistochemistry.
Connection Strength
0.109
-
Veenstra C, Karlsson E, Mirwani SM, Nordenskj?ld B, Fornander T, P?rez-Tenorio G, St?l O. The effects of PTPN2 loss on cell signalling and clinical outcome in relation to breast cancer subtype. J Cancer Res Clin Oncol. 2019 Jul; 145(7):1845-1856.
Score: 0.033
-
Veenstra C, P?rez-Tenorio G, Stelling A, Karlsson E, Mirwani SM, Nordensk?ljd B, Fornander T, St?l O. Met and its ligand HGF are associated with clinical outcome in breast cancer. Oncotarget. 2016 Jun 14; 7(24):37145-37159.
Score: 0.027
-
Bostner J, Karlsson E, Eding CB, Perez-Tenorio G, Franz?n H, Konstantinell A, Fornander T, Nordenskj?ld B, St?l O. S6 kinase signaling: tamoxifen response and prognostic indication in two breast cancer cohorts. Endocr Relat Cancer. 2015 Jun; 22(3):331-43.
Score: 0.026
-
Bojmar L, Karlsson E, Elleg?rd S, Olsson H, Bj?rnsson B, Hallb??k O, Larsson M, St?l O, Sandstr?m P. The role of microRNA-200 in progression of human colorectal and breast cancer. PLoS One. 2013; 8(12):e84815.
Score: 0.023